You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Diagnostic Assays for Rheumatic Diseases

    SBC: JK AUTOIMMUNITY, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The diagnosis of systemic lupus erythematosus is a serious public health problem. Almost 90 percent of the 2,000,000 people who have been told that they have lupus do not fulfill the diagnostic criteria to classify a person as having lupus. The laboratory test used to screen for lupus is largely ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  2. Design of EBVTK substrates to eradicate EBV+ tumors

    SBC: PHARMASSET, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The unique properties of aherpesvirus replicative enzymes have permitted development of antiviral drugs that are converted to cytotoxic compounds exclusively in virus-infected cells. Certain of these proteins form the basis for cytotoxic gene therapy (HSV-1TK and ganciclovir). Although the gherpesvirus EBV encodes similar ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  3. NOVEL DEVICES FOR RAPID BLOOD COMPATIBILITY TESTING

    SBC: TRANSFUSION AND TRANSPLANTATION TECH            Topic: N/A

    The primary objective of these studies is to develop a novel device for rapid, cost-effective, and completely automated pretransfusion compatibility testing. This device will be of interest to Transfusion Medicine services and Blood Banks because it will improve testing throughput while cutting costs. Furthermore, applications are possible in other areas including platelet crossmatching and serolo ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  4. Virtual Reality Exposure Therapy for Social Phobias

    SBC: VIRTUALLY BETTER INC            Topic: N/A

    DESCRIPTION: This study will test the feasibility of virtual reality exposure (VRE) therapy for fear of public speaking. Recent studies suggest social phobia, which includes but is not limited to fear of public speaking, is one of the three most common psychological disorders, with lifetime prevalence rates of 10-13 percent of the general population. Discrete fear of ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government